Markettelegraph.com: Smokefree Innotec, Inc. & Quidel Corporation Profiled by MarketTelegraph.com

Smokefree Innotec, Inc. (PINKSHEETS: SFIO); Quidel Corporation (NASDAQ:QDEL)

MarketTelegraph.com is part of Stock Profiler.US, LLC's News Division. Stock Profiler welcomes investors to sign up at www.stockprofiler.us. to subscribe to our FREE newsletter. Please follow our thread on www.twitter.com at StockProfilerUS. Watch our NEW Video on our Homepage!

Stock Profiler is pleased to introduce Smokefree Innotec, Inc. (PINKSHEETS: SFIO) to the investment community.

http://www.youtube.com/watch?v=SGVA7OcZNPU http://www.youtube.com/watch?v=LlTWQnMOoLY Please visit us at www.stockprofiler.us for more detailed information.

NOTE: All news contained herein has been previously issued by the companies mentioned in this release, and is the property of each company, respectively. All news is edited for content. To read the news in its entirety, go to the Leader in Market News, Stock Profiler.US, LLC (www.stockprofiler.us) click the Headline Tab, enter the ticker symbol and click the news link.

-------------------------------------------

Smokefree Innotec, Inc. closed at $0.046 Thursday, trading 1,258,340 shares.

Smokefree Innotec, Inc.: Smokefree Innotec committing to European MLM relationship yielding potential revenues up to US $25 million

NASHVILLE, TN, Jan 28, 2010 -- Smokefree Innotec, Inc. (Pinksheets:SFIO - News) (http://www.sfio.us or http://www.realsmokefree.com) announced today that its European subsidiary, Smokefree Innotec BvbA, is entering into a contractual relationship with multi-level-marketing (MLM) operator MOMAQ for their distribution of the REAL SMOKEFREE product through their worldwide MLM structure. MOMAQ plans to kick off the program in the Benelux, with fast expansion into Germany, France, Italy and Spain. The terms of the contract provide that MOMAQ place the first order of 5,000 introduction kits. It also provides that MOMAQ guarantees Smokefree Innotec a minimum sales quantity of 250,000 starter kits per year.

About Smokefree Innotec, Inc.

Smokefree Innotec, Inc. is in the business of designing, developing, manufacturing and marketing a Hi-Tech, smokeless cigarette innovation. Real Smokefree is a Patent Pending, odorless, cigarette-style electronic device and is designed to protect the non-smoker from second hand smoke and all its effects, while providing the smoker a way to enjoy a smoke-free cigarette anywhere, including places where smoking is prohibited. Further, our products will allow the smoker to enjoy smoking while not having to worry about the dangers and ill effects of regular cigarette smoking. For more information please visit our website at: www.sfio.us or www.smokefree-innotec.com.

-------------------------------------------

Quidel Corporation closed at $13.33 Thursday, trading 230,300 shares.

Quidel to Hold Fourth Quarter and Full Year 2009 Results Conference Call on February 11, 2010

SAN DIEGO-January 29, 2010 --Quidel Corporation (NASDAQ:QDEL), a leading provider of rapid point-of-care (POC) diagnostic tests, will release fourth quarter and full year 2009 financial results after market close on Thursday, February 11, 2010.

About Quidel Corporation

Quidel Corporation serves to enhance the health and well being of people around the globe through the discovery, development, manufacturing and marketing of rapid diagnostic solutions at the point-of-care (POC) in infectious diseases and reproductive health. Marketed under the leading brand name of QuickVue , Quidel's portfolio of products currently includes tests that aid in the diagnosis of several disease or condition states, including influenza, respiratory syncytial virus, Fecal Occult Blood, Strep A, pregnancy, H. pylori and Chlamydia. Quidel's products are sold to healthcare professionals with a focus on the physician office lab and acute care markets through leading medical distribution partners on a worldwide basis. Quidel's Specialty Products Group (SPG) develops research products in the fields of oncology and bone health with potential future point-of-care applications. By building value in rapid diagnostic tests, Quidel provides leadership to the industry and among healthcare professionals allowing for the movement of patient testing out of the central laboratory setting and into the physician office, urgent care and other outpatient settings where rapid testing and treatment have an impact on clinical outcomes and provide an economic benefit. For more information, visit www.quidel.com, www.colorectal-test.com, www.rsvtesting.com and www.flutest.com.

-------------------------------------------

The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. MarketTelegraph.com is a division of Stock Profiler.US, LLC's News Division, which includes but is not limited to www.stockprofiler.us, www.fastmoneytalk.com, www.associatesfortune.com, www.thewallstreetleader.com and www.daytradersdigest.com. Stock Profiler.US, LLC has been compensated for services rendered; Stock Profiler.US, LLC is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter.

Please consult a broker before purchasing or selling any securities mentioned herein. To view full disclaimers and terms of use, go to www.stockprofiler.us.

Keywords: Small Cap Investments, Investor Relations, I/R Services, Investment Tools, Stock Profiles, Stock Market Quotes, Media Coverage, Google Finance, Google Analytics, Google, Yahoo Finance, Yahoo, MSNBC, Search Engine, AOL Finance, AOL, Market Wire, Businesswire, PR Newswire Alphatrade, Comtex, Comtex A, Comtex B, Zacks, Real Trader, Market News Publications, AFX U.K., Future World, JAGNotes.com, Internetwire, EURO PR News, First Call, PrimeZone, U.S. News, Forbes, Track Notes

CONTACT: Markettelegraph.com Tel: +1 603 424 4420 e-mail: info@stockprofiler.us WWW: http://www.markettelegraph.com

((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

Related terms: advisor, broker, clinical, community, conference, dealer, disease, e-mail, euro, expansion, finance, financial results, france, germany, health, healthcare, investment, investment opinion, italy, manufacturing, market, marketing, media, medical, nasdaq, note, patent, pregnancy, products, research, respiratory, sales, securities, small cap, smoking, spain, track, web